Cerity Partners LLC Increases Position in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Cerity Partners LLC increased its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 1.1% during the third quarter, Holdings Channel reports. The institutional investor owned 81,177 shares of the semiconductor company’s stock after acquiring an additional 915 shares during the period. Cerity Partners LLC’s holdings in Axcelis Technologies were worth $8,511,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Landscape Capital Management L.L.C. purchased a new stake in shares of Axcelis Technologies during the 3rd quarter worth approximately $572,000. Intech Investment Management LLC raised its holdings in Axcelis Technologies by 157.3% during the third quarter. Intech Investment Management LLC now owns 11,094 shares of the semiconductor company’s stock worth $1,163,000 after purchasing an additional 6,782 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in Axcelis Technologies by 12.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 510,894 shares of the semiconductor company’s stock worth $53,568,000 after purchasing an additional 55,048 shares in the last quarter. Advisors Asset Management Inc. grew its holdings in Axcelis Technologies by 27.6% in the third quarter. Advisors Asset Management Inc. now owns 1,293 shares of the semiconductor company’s stock valued at $136,000 after purchasing an additional 280 shares during the last quarter. Finally, Quest Partners LLC increased its position in shares of Axcelis Technologies by 51.2% in the third quarter. Quest Partners LLC now owns 3,975 shares of the semiconductor company’s stock valued at $417,000 after buying an additional 1,346 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have weighed in on ACLS shares. B. Riley dropped their target price on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating for the company in a report on Friday, August 2nd. Benchmark cut shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Stock Performance

Shares of NASDAQ ACLS opened at $74.45 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29. The company has a market cap of $2.42 billion, a PE ratio of 11.01, a price-to-earnings-growth ratio of 2.34 and a beta of 1.60. The company has a 50-day simple moving average of $91.06 and a 200-day simple moving average of $110.67. Axcelis Technologies, Inc. has a 12 month low of $69.35 and a 12 month high of $158.61.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.